Life Science REIT Balance Sheet Health
Financial Health criteria checks 2/6
Life Science REIT has a total shareholder equity of £283.7M and total debt of £107.9M, which brings its debt-to-equity ratio to 38%. Its total assets and total liabilities are £410.7M and £127.0M respectively. Life Science REIT's EBIT is £8.6M making its interest coverage ratio 1.4. It has cash and short-term investments of £14.3M.
Key information
38.0%
Debt to equity ratio
UK£107.92m
Debt
Interest coverage ratio | 1.4x |
Cash | UK£14.34m |
Equity | UK£283.75m |
Total liabilities | UK£126.96m |
Total assets | UK£410.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LABS's short term assets (£21.0M) exceed its short term liabilities (£14.4M).
Long Term Liabilities: LABS's short term assets (£21.0M) do not cover its long term liabilities (£112.5M).
Debt to Equity History and Analysis
Debt Level: LABS's net debt to equity ratio (33%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if LABS's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LABS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LABS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.